HeartBeam (NASDAQ: BEAT) is positioned amid limitations of traditional 12-lead electrocardiogram ("ECG") systems, often ...
ECG detects cardiac sarcoidosis with a high sensitivity and negative predictive value in patients with cutaneous sarcoidosis.
Please provide your email address to receive an email when new articles are posted on . Patients with positive ECG results and normal stress echocardiography had a slightly increased risk for adverse ...
Austin, Texas, United States, September 29th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT) is positioned amid limitations of traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results